Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-27 17:45 |
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Hea…
|
English | 165.4 KB | ||
| 2025-10-09 16:01 |
Franchissement de seuil
|
French | 115.0 KB | ||
| 2025-10-09 15:59 |
Franchissement de seuil
|
French | 205.6 KB | ||
| 2025-10-06 17:35 |
Valneva consolide sa position de trésorerie en refinançant sa dette auprès de P…
|
French | 202.1 KB | ||
| 2025-10-06 17:35 |
Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advis…
|
English | 212.7 KB | ||
| 2025-10-06 07:30 |
VALNEVA Déclaration d’actions et de droits de vote : 30 septembre 2025
|
French | 199.8 KB | ||
| 2025-10-06 07:30 |
VALNEVA Declaration of shares and voting rights: September 30, 2025
|
English | 210.9 KB | ||
| 2025-09-30 07:00 |
Valneva Reports 95% Seroresponse Four Years After Single Shot of Chikungunya Va…
|
English | 259.8 KB | ||
| 2025-09-30 07:00 |
Valneva annonce un taux de séroréponse de 95% quatre ans après une vaccination …
|
French | 243.6 KB | ||
| 2025-09-03 18:00 |
VALNEVA Déclaration d’actions et de droits de vote : 31 août 2025
|
French | 202.1 KB | ||
| 2025-09-03 18:00 |
VALNEVA Declaration of shares and voting rights: August 31, 2025
|
English | 211.1 KB | ||
| 2025-09-03 07:00 |
Valneva annonce de nouvelles données positives d’innocuité et d’immunogénicité …
|
French | 215.3 KB | ||
| 2025-08-25 07:00 |
Valneva annonce la décision de la FDA de suspendre la licence d’IXCHIQ® aux Éta…
|
French | 226.3 KB | ||
| 2025-08-25 07:00 |
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCH…
|
English | 239.2 KB | ||
| 2025-08-18 07:00 |
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals …
|
English | 205.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
